These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15467503)

  • 21. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HCV antibodies in hemodialyzed patients in Tunisia].
    Hmida S; Mojaat N; Chaouchi E; Mahjoub T; Khlass B; Abid S; Boukef K
    Pathol Biol (Paris); 1995 Sep; 43(7):581-3. PubMed ID: 8570261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin.
    Viganò M; Aghemo A; Iavarone M; Rumi MG; Agnelli F; Lampertico P; Donato MF; Colombo M
    Antivir Ther; 2009; 14(6):789-96. PubMed ID: 19812441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
    Mederacke I; Meier M; Lüth JB; Schmidt-Gürtler H; Raupach R; Horn-Wichmann R; Wursthorn K; Potthoff A; Colucci G; Manns MP; Wedemeyer H; Tillmann HL
    Nephrol Dial Transplant; 2011 Aug; 26(8):2648-56. PubMed ID: 21273235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Incidence and prevalence of anti-HVC antibodies and HBV markers in patients undergoing extracorporeal hemodialysis].
    Incandela L; Giomi S; Nencioni C; Riccardi MP; Galluzzi P; Caponetti R; Domenici P; Toti M
    Minerva Med; 1994 Oct; 85(10):505-9. PubMed ID: 7800191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Control of HCV, HBV and HIV Infections in Hemodialysis].
    Fabrizi F; Martin P; Messa P
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24403201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
    Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen CH; Changchien CS
    J Gastroenterol Hepatol; 2005 May; 20(5):727-32. PubMed ID: 15853986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis and transfusions.
    Donnelly K
    Nephrol Nurs J; 2000 Oct; 27(5):538-9. PubMed ID: 16649331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection.
    Yeh ML; Hsieh MY; Huang CI; Huang CF; Hsieh MH; Huang JF; Dai CY; Chuang WL; Yu ML
    J Gastroenterol Hepatol; 2016 Apr; 31(4):835-41. PubMed ID: 26478984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B and C status among health care workers in the five main hospitals in eastern Libya.
    Elzouki AN; Elgamay SM; Zorgani A; Elahmer O
    J Infect Public Health; 2014; 7(6):534-41. PubMed ID: 25151657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis].
    Zwolińska D; Inglot M; Makulska I; Gładysz A; Szprynger K; Szczepańska M; Pietrzyk J; Zachwieja K; Zurowska A; Zachwieja J; Rajkowski T; Jobs K; Latoszyńska J; Jander A
    Pol Merkur Lekarski; 2001 Apr; 10(58):267-70. PubMed ID: 11434173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF
    J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances on hepatitis C virus in dialysis population.
    Fabrizi F; Messa P; Martin P
    Kidney Blood Press Res; 2014; 39(4):260-71. PubMed ID: 25171295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National surveillance of dialysis-associated diseases in the United States, 2002.
    Finelli L; Miller JT; Tokars JI; Alter MJ; Arduino MJ
    Semin Dial; 2005; 18(1):52-61. PubMed ID: 15663766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for hepatitis B, C and HIV infection among patients on haemodialysis (cross sectional analysis among patients from two dialysis units in the period January to July 2005).
    Bosevska G; Kuzmanovska G; Sikole A; Dzekova-Vidimilski P; Polenakovic M
    Prilozi; 2009 Dec; 30(2):159-74. PubMed ID: 20087257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Natural history of hepatitis C virus infection in dialysis].
    Fabrizi F; Martin P; Lunghi G; Ponticelli C
    G Ital Nefrol; 2003; 20(5):470-7. PubMed ID: 14634962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.